Mikhail Blagosklonny Fights Cancer through TOR Signaling


The world’s largest medical problem in this century is cancer. The most devastating fact about this life threatening disease is its silent growth in the body. Not only is it difficult for physicians to detect cancer at an early stage, but also, finding the right treatment for the disease is an uphill task. Most cancer patients have lost this battle because, like fire, it consumes all the active and healthy parts of the body’s immunity. With that said, many scientists have taken it upon themselves to study the human body and how cancer cells multiply within the active, healthy cells. One such scientist is Mikhail Blagosklonny.

Know more: http://gettingstronger.org/tag/mikhail-blagosklonny/

TOR Signaling

Mikhail is a scientist. He specializes in the study of cancer and aging. Over the past years, he has been working on finding treatment for cancer through therapies. Following his vast experience in science and age-related disease, Mikhail formulated a hypothesis called TOR Signaling. According to this hypothesis, there is a possibility of TOR Signaling treating cancer. This way, rapamycin will be used, and the result would be beating the aging process hence curbing all age-related disease. To Mikhail, this is the cure for life extension. Mr. Blagosklonny is considered a passionate supporter of rapamycin. He has been an active participant in longevity research.

Education and Career

Blagosklonny’s first education degree was acquired from the University of Petersburg. In this school, he studied internal medicine and earned a PhD in medicine and cardiology. Following his academic credentials, he was appointed the associate professor for a medical college in New York City. In 2002, Mikhail Blagosklonny was trusted with the position of senior scientist in Ordway Institute of Research. This facility is geographically located in Albany, New York. He was responsible for daily operations of the organization until 2009.

After that experience, Blagosklonny landed a huge position at Roswell Institute of Cancer Research. Blagosklonny has been passionate in the field of cancer research. With his scientific knowledge, he develops cancer therapies generating from normally damaged cells. To Blagosklonny, the fight against cancer is on, and the best way around it is investing time and resources towards research. Visit ResearchGate.Net to learn more about Mikhail’s latest work.

Leave a Reply

Your email address will not be published. Required fields are marked *